Oncogenic Functions and Clinical Significance of Circular RNAs in Colorectal Cancer.

circRNAs circular RNAs colorectal cancer oncogenic

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
06 Jul 2021
Historique:
received: 17 05 2021
revised: 13 06 2021
accepted: 02 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 25 7 2021
Statut: epublish

Résumé

Colorectal cancer (CRC) is ranked as the second most commonly diagnosed disease in females and the third in males worldwide. Therefore, the finding of new more reliable biomarkers for early diagnosis, for prediction of metastasis, and resistance to conventional therapies is an important challenge in overcoming the disease. The current review presents circular RNAs (circRNAs) with their unique features as potential prognostic and diagnostic biomarkers in CRC. The review highlights the mechanism of action and the role of circRNAs with oncogenic functions in the CRC as well as the association between their expression and clinicopathological characteristics of CRC patients. The comprehension of the role of oncogenic circRNAs in CRC pathogenesis is growing rapidly and the next step is using them as suitable new drug targets in the personalized treatment of CRC patients.

Identifiants

pubmed: 34298612
pii: cancers13143395
doi: 10.3390/cancers13143395
pmc: PMC8303601
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Bulgarian National Science Fund
ID : К∏-06-H23/6,18.12.2018

Références

Mol Med Rep. 2019 Jan;19(1):638-650
pubmed: 30483740
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4190-4202
pubmed: 32373955
Front Oncol. 2020 May 20;10:663
pubmed: 32670861
Biomed Res Int. 2017;2017:8421614
pubmed: 28656150
Sci Rep. 2016 Oct 11;6:34985
pubmed: 27725737
Database (Oxford). 2011 Nov 26;2011:bar053
pubmed: 22120664
Cancer Biomark. 2020;29(4):531-542
pubmed: 32865180
Nucleic Acids Res. 2019 Jul 9;47(12):6452-6465
pubmed: 31032518
Cancer Manag Res. 2020 Sep 14;12:8465-8479
pubmed: 32982440
Onco Targets Ther. 2019 Oct 07;12:8249-8261
pubmed: 31632075
Mol Cancer. 2020 Jan 31;19(1):20
pubmed: 32005118
Epigenomics. 2019 Jun;11(8):875-884
pubmed: 31020847
Am J Transl Res. 2020 Jun 15;12(6):2554-2569
pubmed: 32655790
RNA Biol. 2017 Aug 3;14(8):992-999
pubmed: 27617908
BMC Microbiol. 2006 Mar 06;6:24
pubmed: 16519798
Nat Rev Cancer. 2010 Dec;10(12):858-70
pubmed: 21102636
Onco Targets Ther. 2017 Apr 07;10:2045-2056
pubmed: 28435295
Cell Rep. 2015 Jan 13;10(2):170-7
pubmed: 25558066
Genomics Proteomics Bioinformatics. 2020 Apr;18(2):129-139
pubmed: 32512182
Semin Cancer Biol. 2021 Oct;75:49-61
pubmed: 33035655
Theranostics. 2020 Jul 9;10(18):8211-8226
pubmed: 32724467
Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):118-126
pubmed: 29364478
Onco Targets Ther. 2020 Jun 12;13:5529-5539
pubmed: 32606768
Arch Biochem Biophys. 2020 Aug 15;689:108434
pubmed: 32473899
RNA Biol. 2016;13(1):34-42
pubmed: 26669964
Cell Death Dis. 2018 Mar 16;9(4):417
pubmed: 29549306
BMC Syst Biol. 2014;8 Suppl 3:S2
pubmed: 25350788
J Cell Physiol. 2020 Jan 21;:
pubmed: 31960446
Mol Cell. 2014 Oct 2;56(1):55-66
pubmed: 25242144
Nat Struct Mol Biol. 2015 Mar;22(3):256-64
pubmed: 25664725
Int J Mol Sci. 2019 Aug 13;20(16):
pubmed: 31412535
Onco Targets Ther. 2020 May 12;13:4035-4048
pubmed: 32494158
Mol Oncol. 2020 Mar;14(3):539-555
pubmed: 31901148
RNA. 2014 Nov;20(11):1666-70
pubmed: 25234927
Cancer Manag Res. 2020 Aug 04;12:6795-6806
pubmed: 32821160
J Clin Oncol. 2000 Aug;18(16):2938-47
pubmed: 10944126
Front Cell Dev Biol. 2021 Jan 15;8:604869
pubmed: 33520987
Cancer Cell Int. 2019 Nov 04;19:276
pubmed: 31700498
Cancer Manag Res. 2020 Aug 10;12:7107-7116
pubmed: 32848465
Cancer Cell Int. 2020 Oct 12;20:494
pubmed: 33061846
Anticancer Drugs. 2021 Jun 1;32(6):635-646
pubmed: 33595945
Onco Targets Ther. 2019 May 23;12:4065-4073
pubmed: 31213828
Onco Targets Ther. 2021 Jan 18;14:491-502
pubmed: 33500625
Int J Mol Sci. 2014 May 26;15(6):9331-42
pubmed: 24865493
Cancer Lett. 2017 Sep 28;404:8-18
pubmed: 28705773
PLoS One. 2012;7(2):e30733
pubmed: 22319583
EMBO Mol Med. 2019 Oct;11(10):e10168
pubmed: 31475771
J Mol Biol. 2015 Jul 31;427(15):2414-2417
pubmed: 25728652
J Cell Mol Med. 2020 Mar;24(6):3431-3437
pubmed: 32020730
Mol Ther. 2020 Mar 4;28(3):914-928
pubmed: 31951832
J Cell Physiol. 2020 Mar;235(3):2881-2890
pubmed: 31549406
Mol Cell. 2017 Apr 6;66(1):22-37.e9
pubmed: 28344082
Biochem Biophys Res Commun. 2018 Sep 26;504(1):184-189
pubmed: 30173892
Mol Cancer. 2019 Jan 10;18(1):8
pubmed: 30630466
RNA. 2003 Mar;9(3):319-30
pubmed: 12592006
Crit Rev Oncol Hematol. 2020 Jan;145:102854
pubmed: 31877535
Nat Med. 2009 Jan;15(1):59-67
pubmed: 19098908
Cell Death Dis. 2020 Aug 14;11(8):625
pubmed: 32796815
Cell Death Differ. 2019 Dec;26(12):2758-2773
pubmed: 31092884
Cancers (Basel). 2020 Mar 16;12(3):
pubmed: 32187976
Cell Res. 2015 Aug;25(8):981-4
pubmed: 26138677
Carcinogenesis. 2021 Apr 30;42(4):601-610
pubmed: 33347535
Oncol Rep. 2019 Oct;42(4):1459-1466
pubmed: 31322270
Wiley Interdiscip Rev RNA. 2014 May-Jun;5(3):317-33
pubmed: 24375960
Oncotarget. 2017 Oct 10;8(53):91674-91683
pubmed: 29207676
J Biol Res (Thessalon). 2021 Feb 27;28(1):7
pubmed: 33640021
Mol Cancer. 2017 Mar 29;16(1):70
pubmed: 28356111
Cancer Biother Radiopharm. 2021 Feb;36(1):45-57
pubmed: 32379550
Cancer Manag Res. 2019 Jul 23;11:6887-6893
pubmed: 31413634
Biol Chem. 2020 Mar 26;401(4):487-496
pubmed: 31747371
Mol Cancer Ther. 2019 Aug;18(8):1386-1395
pubmed: 31092563
Cancer Res. 2019 Feb 1;79(3):557-571
pubmed: 30563889
Mol Cancer. 2020 Jan 23;19(1):13
pubmed: 31973707
Cell Rep. 2015 Jan 6;10(1):103-11
pubmed: 25543144
Gastroenterol Res Pract. 2020 Dec 9;2020:8834359
pubmed: 33376485
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):7963-7971
pubmed: 32767322
Onco Targets Ther. 2020 Jul 28;13:7357-7368
pubmed: 32821119
Cell. 2014 Sep 25;159(1):134-147
pubmed: 25242744
Nat Commun. 2019 Oct 16;10(1):4695
pubmed: 31619685
Int J Clin Exp Pathol. 2014 Jul 15;7(8):4867-76
pubmed: 25197357
Biochem Biophys Res Commun. 2019 May 14;512(4):716-722
pubmed: 30922567
Pathol Res Pract. 2020 Apr;216(4):152861
pubmed: 32061452
Onco Targets Ther. 2016 Aug 12;9:5023-39
pubmed: 27574444
Neoplasma. 2020 Sep;67(5):1063-1073
pubmed: 32567935
Cell Death Dis. 2020 May 11;11(5):356
pubmed: 32393760
J BUON. 2018 Sep-Oct;23(5):1343-1349
pubmed: 30570857
Front Genet. 2013 Dec 10;4:283
pubmed: 24339831
Sci Rep. 2017 Feb 06;7:41942
pubmed: 28165066
Front Genet. 2019 Nov 01;10:1096
pubmed: 31737058
Cancer Manag Res. 2020 Dec 15;12:12853-12865
pubmed: 33364834
J Oncol. 2019 Jun 26;2019:9836819
pubmed: 31346335
Nucleic Acids Res. 2016 Apr 7;44(6):2846-58
pubmed: 26861625
Oncol Lett. 2020 Jul;20(1):266-274
pubmed: 32565953
Front Genet. 2020 Feb 25;11:9
pubmed: 32158464
Cancer Cell Int. 2020 Nov 19;20(1):557
pubmed: 33292256
Pathol Res Pract. 2019 Apr;215(4):689-696
pubmed: 30630646
Anticancer Drugs. 2021 Mar 1;32(3):296-305
pubmed: 33534412
Front Genet. 2020 May 08;11:357
pubmed: 32508871
Cell Biosci. 2019 Dec 2;9:97
pubmed: 31827763
J Cell Physiol. 2019 May;234(5):7247-7256
pubmed: 30370521
Clin Cancer Res. 2012 Mar 15;18(6):1696-703
pubmed: 22282467
Oncol Rep. 2018 Jul;40(1):283-293
pubmed: 29749494
J Exp Clin Cancer Res. 2020 May 19;39(1):91
pubmed: 32430042
Am J Transl Res. 2020 Jan 15;12(1):281-291
pubmed: 32051753
J Biochem. 2020 Jan 1;167(1):55-65
pubmed: 31598673
Cancer Cell Int. 2020 May 19;20:173
pubmed: 32467668
Anticancer Drugs. 2021 Jan 1;32(1):22-33
pubmed: 32889894
Mol Ther Nucleic Acids. 2019 Dec 6;18:375-387
pubmed: 31648103
Int J Mol Sci. 2020 Nov 23;21(22):
pubmed: 33238574
Mol Cancer. 2016 Dec 5;15(1):78
pubmed: 27919264
J Cell Mol Med. 2020 May;24(9):5021-5027
pubmed: 32243061
EMBO J. 2014 Jul 1;33(13):1454-73
pubmed: 24825347
Int J Cancer. 2014 Feb 15;134(4):997-1007
pubmed: 23934972
RNA. 2014 Dec;20(12):1829-42
pubmed: 25404635
J Cancer. 2021 Jan 16;12(6):1678-1686
pubmed: 33613755
Biomed Pharmacother. 2018 Jun;102:1188-1194
pubmed: 29710537
Cell. 2015 Mar 12;160(6):1125-34
pubmed: 25768908
Adv Exp Med Biol. 2016;924:91-95
pubmed: 27753025
Cell Metab. 2019 Jul 2;30(1):157-173.e7
pubmed: 31155494
J Cell Mol Med. 2021 Apr;25(8):3667-3679
pubmed: 33687140
Int J Oncol. 2020 Jul;57(1):21-42
pubmed: 32377736
Cancer Cell Int. 2021 Mar 4;21(1):153
pubmed: 33663510
Cancer Manag Res. 2021 Feb 18;13:1673-1686
pubmed: 33628056
World J Gastroenterol. 2014 Feb 28;20(8):1940-50
pubmed: 24616570
Cancer Treat Rev. 2018 Jan;62:50-60
pubmed: 29169144
Clin Chem. 2015 Jan;61(1):221-30
pubmed: 25376581
Biomed Pharmacother. 2019 Apr;112:108611
pubmed: 30797148
Exp Ther Med. 2020 May;19(5):3355-3361
pubmed: 32266033
Clin Cancer Res. 2017 Jul 15;23(14):3918-3928
pubmed: 28174233
ESMO Open. 2020 Aug;4(Suppl 2):e000813
pubmed: 32817137
J Cell Mol Med. 2020 Sep;24(17):9908-9924
pubmed: 32681581
Int J Cancer. 2022 Mar 1;150(5):E3
pubmed: 31269234
Clin Chim Acta. 2015 Apr 15;444:132-6
pubmed: 25689795
Onco Targets Ther. 2019 Aug 09;12:6349-6359
pubmed: 31496737
Oncotarget. 2015 Aug 21;6(24):20672-84
pubmed: 26009899
Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9
pubmed: 25190710
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2387-2400
pubmed: 32196590
Front Oncol. 2020 Jun 18;10:982
pubmed: 32626660
Oncol Lett. 2019 Sep;18(3):3097-3103
pubmed: 31452787
Biochem Biophys Res Commun. 2020 Apr 16;524(4):839-846
pubmed: 32046858
J Exp Clin Cancer Res. 2020 Dec 14;39(1):283
pubmed: 33317596
Cell. 2019 Feb 7;176(4):869-881.e13
pubmed: 30735636
Int J Clin Exp Pathol. 2018 Mar 01;11(3):1399-1406
pubmed: 31938236
Cell Physiol Biochem. 2018;49(4):1539-1550
pubmed: 30212824
Neoplasia. 2016 Nov;18(11):654-665
pubmed: 27764698
Biomed Pharmacother. 2017 Apr;88:138-144
pubmed: 28103507
Mol Cell Biol. 2020 Apr 13;40(9):
pubmed: 32041821
J Cell Biol. 1992 Nov;119(3):503-12
pubmed: 1383233
Mol Cancer. 2017 Mar 9;16(1):58
pubmed: 28279183
Cancer Biother Radiopharm. 2021 Nov;36(9):737-752
pubmed: 32343603
Cancer Manag Res. 2021 Mar 23;13:2717-2731
pubmed: 33790646
J Mol Cell Biol. 2019 Oct 25;11(10):911-919
pubmed: 31504667
Nucleic Acids Res. 2020 Aug 20;48(14):7609-7622
pubmed: 32476018
Nucleic Acids Res. 1992 Oct 25;20(20):5345-50
pubmed: 1437551
Oncol Rep. 2020 Nov;44(5):2009-2020
pubmed: 32901890
Cell Res. 2017 May;27(5):626-641
pubmed: 28281539
Cancer Cell Int. 2020 Sep 03;20:430
pubmed: 32908453
Mol Cell. 2015 Jun 4;58(5):870-85
pubmed: 25921068
DNA Cell Biol. 2020 Jan;39(1):118-125
pubmed: 31859543
Sci Rep. 2019 Nov 11;9(1):16497
pubmed: 31712601
Cell Biol Int. 2017 Sep;41(9):1056-1064
pubmed: 28707774
PLoS One. 2015 Oct 20;10(10):e0141214
pubmed: 26485708
Int J Cancer. 2018 May 1;142(9):1853-1864
pubmed: 29226323
Biomed Pharmacother. 2021 May;137:111351
pubmed: 33550046
Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6315-20
pubmed: 19325125
Trends Genet. 2016 May;32(5):309-316
pubmed: 27050930
Elife. 2015 Jun 09;4:e07540
pubmed: 26057830
Int J Mol Med. 2017 Dec;40(6):1818-1828
pubmed: 29039473
J Pathol. 2019 May;248(1):103-115
pubmed: 30666650
Cell. 2011 Aug 5;146(3):353-8
pubmed: 21802130
Eur Rev Med Pharmacol Sci. 2020 Nov;24(22):11587-11593
pubmed: 33275225
Onco Targets Ther. 2020 Jun 30;13:6315-6327
pubmed: 32636650
Cancer Res. 2017 May 1;77(9):2339-2350
pubmed: 28249903
Adv Exp Med Biol. 2021;1275:357-382
pubmed: 33539023
Cancer Cell Int. 2020 Mar 30;20:103
pubmed: 32256212
Oncotarget. 2016 May 3;7(18):26680-91
pubmed: 27058418
Genome Biol. 2014 Jul 29;15(7):409
pubmed: 25070500
Cancers (Basel). 2020 Aug 31;12(9):
pubmed: 32878117
Mol Ther. 2019 Aug 7;27(8):1350-1363
pubmed: 31324392
Onco Targets Ther. 2020 Jun 23;13:5939-5953
pubmed: 32606803
J Clin Lab Anal. 2020 Jul;34(7):e23359
pubmed: 32419229
Cell Death Dis. 2020 Sep 23;11(9):788
pubmed: 32968054
Aging (Albany NY). 2021 Feb 11;13(4):5892-5905
pubmed: 33591945
Connect Tissue Res. 2015;56(5):403-13
pubmed: 26291767
Front Oncol. 2020 Jun 16;10:850
pubmed: 32612946
Am J Transl Res. 2020 Nov 15;12(11):7395-7403
pubmed: 33312376
Cancer Biol Ther. 2020 Aug 2;21(8):733-740
pubmed: 32564659
Onco Targets Ther. 2019 Jun 19;12:4765-4777
pubmed: 31354303
Med Sci Monit. 2019 Sep 13;25:6872-6883
pubmed: 31515467
Cell Death Dis. 2020 Jul 17;11(7):542
pubmed: 32681092
J Cell Biochem. 2020 Jun;121(5-6):3286-3297
pubmed: 31960989
Clin Cancer Res. 2011 Jun 1;17(11):3569-78
pubmed: 21474578
Nat Plants. 2017 Apr 18;3:17053
pubmed: 28418376
Curr Colorectal Cancer Rep. 2018 Dec;14(6):226-241
pubmed: 31406492
Cell Prolif. 2020 Jul;53(7):e12815
pubmed: 32515024
Matrix Biol. 2014 Feb;34:185-92
pubmed: 24361528
Front Immunol. 2021 Feb 03;11:617583
pubmed: 33613544
Mol Cancer. 2020 Mar 18;19(1):60
pubmed: 32188489
RNA. 2013 Feb;19(2):141-57
pubmed: 23249747
Onco Targets Ther. 2016 Dec 09;9:7451-7458
pubmed: 28003761
Cancer Med. 2020 Sep;9(18):6710-6725
pubmed: 32706154
Mol Cancer. 2018 Aug 15;17(1):123
pubmed: 30111313
Nature. 2013 Mar 21;495(7441):384-8
pubmed: 23446346
J Mol Med (Berl). 2015 Mar;93(3):315-26
pubmed: 25388617
Onco Targets Ther. 2020 May 01;13:3689-3701
pubmed: 32431519
Onco Targets Ther. 2020 Jan 14;13:423-434
pubmed: 32021287
Cancer Manag Res. 2020 Jun 23;12:4899-4910
pubmed: 32606978
Mol Cell. 2018 Aug 2;71(3):428-442
pubmed: 30057200
Cancer Manag Res. 2020 Nov 04;12:11257-11269
pubmed: 33177876
Mol Cell. 2017 Apr 6;66(1):9-21.e7
pubmed: 28344080
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3311-3319
pubmed: 31081084
Cell Death Dis. 2018 Oct 10;9(10):1037
pubmed: 30305607
Int J Biochem Cell Biol. 2010 Jul;42(7):1061-5
pubmed: 20348011
Clin Biochem. 2019 Dec;74:60-68
pubmed: 31669510
RNA. 2015 Jul;21(7):1286-93
pubmed: 25956521
Int J Biol Sci. 2017 Nov 2;13(12):1497-1506
pubmed: 29230098
Oncol Rep. 2019 May;41(5):2717-2728
pubmed: 30896866
Mol Cancer. 2019 Mar 29;18(1):47
pubmed: 30925892
Cancer Manag Res. 2020 Oct 02;12:9563-9575
pubmed: 33061642
Nucleic Acids Res. 2016 Jan 4;44(D1):D209-15
pubmed: 26450965
Int J Biol Sci. 2021 Jan 1;17(1):379-389
pubmed: 33390857
Mol Cancer. 2020 Nov 23;19(1):164
pubmed: 33225938
Genes (Basel). 2016 Jul 18;7(7):
pubmed: 27438857
Cancer Sci. 2019 Jan;110(1):86-98
pubmed: 30320939
Mol Cancer. 2020 Jan 23;19(1):14
pubmed: 31973726
J Clin Lab Anal. 2020 Sep;34(9):e23405
pubmed: 32633429
Am J Transl Res. 2020 Oct 15;12(10):6490-6500
pubmed: 33194046
Nat Biotechnol. 2014 May;32(5):453-61
pubmed: 24811520
Biosci Rep. 2020 Mar 27;40(3):
pubmed: 32149326
Mol Cell Biol. 2021 Jan 25;41(2):
pubmed: 33257506
J Cell Biochem. 2019 Mar;120(3):3027-3037
pubmed: 30520100
Nucleic Acids Res. 1996 Apr 1;24(7):1260-6
pubmed: 8614628
PLoS One. 2014 Feb 13;9(2):e88393
pubmed: 24551096
Biol Proced Online. 2020 May 15;22:10
pubmed: 32467674
Cancer Manag Res. 2019 Jun 11;11:5413-5423
pubmed: 31354349
Biomed Pharmacother. 2018 Sep;105:879-886
pubmed: 30021381
Semin Cell Dev Biol. 2020 Feb;98:63-70
pubmed: 31129171
World J Gastroenterol. 2019 Sep 21;25(35):5300-5309
pubmed: 31558874
Cells. 2019 Dec 20;9(1):
pubmed: 31861825
Cell Death Dis. 2020 Jul 22;11(7):557
pubmed: 32699205
Int J Biol Markers. 2019 Sep;34(3):284-291
pubmed: 31476947
Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4730-4737
pubmed: 31210299
Mol Cancer. 2021 Feb 3;20(1):26
pubmed: 33536039
Mol Cancer. 2020 Jul 27;19(1):117
pubmed: 32713345
FASEB J. 1993 Jan;7(1):155-60
pubmed: 7678559
Aging (Albany NY). 2020 Jul 8;12(13):13338-13353
pubmed: 32644049
Proc Natl Acad Sci U S A. 1976 Nov;73(11):3852-6
pubmed: 1069269
Oncogene. 2019 Aug;38(32):6017-6034
pubmed: 31300733
Eur J Cancer. 2017 Nov;86:150-157
pubmed: 28988015
RNA Biol. 2017 Aug 3;14(8):1007-1017
pubmed: 27571848
Mol Cell. 2013 Sep 26;51(6):792-806
pubmed: 24035497
Clin Sci (Lond). 2019 Dec 20;133(24):2463-2479
pubmed: 31738400
Mol Cancer Res. 2015 Aug;13(8):1248-62
pubmed: 25934695

Auteurs

Maria Radanova (M)

Department of Biochemistry, Molecular Medicine and Nutrigenomics, Medical University of Varna, 9000 Varna, Bulgaria.
Laboratory of Molecular Pathology, University Hospital "St. Marina", 9000 Varna, Bulgaria.

Galya Mihaylova (G)

Department of Biochemistry, Molecular Medicine and Nutrigenomics, Medical University of Varna, 9000 Varna, Bulgaria.

Neshe Nazifova-Tasinova (N)

Department of Biochemistry, Molecular Medicine and Nutrigenomics, Medical University of Varna, 9000 Varna, Bulgaria.

Mariya Levkova (M)

Department of Medical Genetics, Molecular Medicine and Nutrigenomics, Medical University of Varna, 9000 Varna, Bulgaria.

Oskan Tasinov (O)

Department of Biochemistry, Molecular Medicine and Nutrigenomics, Medical University of Varna, 9000 Varna, Bulgaria.

Desislava Ivanova (D)

Department of Biochemistry, Molecular Medicine and Nutrigenomics, Medical University of Varna, 9000 Varna, Bulgaria.

Zhasmina Mihaylova (Z)

Clinic of Medical Oncology, Military Medical Academy, 1000 Sofia, Bulgaria.

Ivan Donev (I)

Clinic of Medical Oncology, Hospital Nadezhda, 1000 Sofia, Bulgaria.

Classifications MeSH